Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Big Pharma Voluntary List Price Reductions Doubtful, Sen. Warren Says

Executive Summary

Companies responding to inquiries from Sens. Elizabeth Warren, D-Mass., and Tina Smith, D-Minn., did not indicate they are planning to reduce list prices, despite promises by President Trump, Warren told a June 12 hearing. 
Advertisement

Related Content

Merck's New Pricing Pledge Shows Style Over Substance
Pfizer Agrees To Roll Back Prices On 40 Drugs, Yielding To Pressure From Trump
Pfizer Agrees To Roll Back Prices On 40 Drugs, Yielding To Pressure From Trump
US Senators Seek 'Clarity’ On Middlemen Obstructing List Price Reductions
Trump Expecting Rx Price Reduction Announcements In Two Weeks

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC123253

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel